Outlook Therapeutics
Dan Courtney is an experienced finance professional with a diverse background in accounting and financial management across various companies. Currently serving as a Consultant at Outlook Therapeutics, Inc. since June 2023, Dan previously held positions including Senior Manager of Finance at Ajanta Pharma USA Inc., where oversight of accounts payable and receivable was a key responsibility, and Accounting Consultant at Torrent Pharma Inc., leading a team in daily accounting operations. Additional roles include Senior Manager of Corporate Accounting at Adare Pharma Solutions, where Dan contributed to the establishment of financial statements and audits, as well as positions at Vaco Resources and Cisco Systems, focusing on revenue and financial planning. Dan's career also includes significant financial leadership roles at WiderThan Americas and Convergys, as well as experience in financial reporting at ORBCOMM. Dan holds a Bachelor of Science in Commerce from the University of Virginia.
This person is not in any teams
Outlook Therapeutics
Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010 / LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, including wet AMD, DME and BRVO.